IN2015MN00038A - - Google Patents

Info

Publication number
IN2015MN00038A
IN2015MN00038A IN38MUN2015A IN2015MN00038A IN 2015MN00038 A IN2015MN00038 A IN 2015MN00038A IN 38MUN2015 A IN38MUN2015 A IN 38MUN2015A IN 2015MN00038 A IN2015MN00038 A IN 2015MN00038A
Authority
IN
India
Prior art keywords
formulations
infection
anthrax
vaccine
antigen
Prior art date
Application number
Other languages
English (en)
Inventor
Jee Look
Christian Fernando Ruiz
Aaron Paul Miles
Richard William Welch
Original Assignee
Emergent Product Dev Gaithersburg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emergent Product Dev Gaithersburg Inc filed Critical Emergent Product Dev Gaithersburg Inc
Publication of IN2015MN00038A publication Critical patent/IN2015MN00038A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/07Bacillus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IN38MUN2015 2012-06-25 2013-06-25 IN2015MN00038A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261664062P 2012-06-25 2012-06-25
US201361801385P 2013-03-15 2013-03-15
PCT/US2013/047712 WO2014004578A1 (en) 2012-06-25 2013-06-25 Temperature stable vaccine formulations

Publications (1)

Publication Number Publication Date
IN2015MN00038A true IN2015MN00038A (es) 2015-10-16

Family

ID=49783811

Family Applications (1)

Application Number Title Priority Date Filing Date
IN38MUN2015 IN2015MN00038A (es) 2012-06-25 2013-06-25

Country Status (13)

Country Link
US (1) US20150335752A1 (es)
EP (1) EP2863898A4 (es)
JP (1) JP2015525748A (es)
KR (1) KR20150034170A (es)
CN (1) CN104470506A (es)
AU (1) AU2013280480B2 (es)
CA (1) CA2877130A1 (es)
HK (1) HK1207312A1 (es)
IL (1) IL236380A0 (es)
IN (1) IN2015MN00038A (es)
RU (1) RU2014151424A (es)
SG (1) SG11201408262XA (es)
WO (1) WO2014004578A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100344A1 (en) * 2013-12-27 2015-07-02 Emergent Product Development Gaithersburg Inc. Temperature stable vaccine formulations
EP3089754B1 (en) * 2013-12-31 2021-04-21 Infectious Disease Research Institute Single vial vaccine formulations
EP3319930A4 (en) * 2015-07-07 2019-04-10 NanoBio Corporation METHOD AND COMPOSITIONS FOR STABILIZING PROTEINS
US20170007690A1 (en) * 2015-07-07 2017-01-12 Nanobio Corporation Methods and compositions for the stabilization of anthrax recombinant protective antigen
WO2017007835A1 (en) 2015-07-07 2017-01-12 Nanobio Corporation Methods and compositions for nanoemulsion vaccine formulations
EP3512496A1 (en) 2016-09-16 2019-07-24 Leukocare Ag A novel method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
US20190216925A1 (en) 2016-09-16 2019-07-18 Leukocare Ag A Novel Method for Stabilization of a Biopharmaceutical Drug Product During Processing
KR101744900B1 (ko) 2017-01-20 2017-06-08 주식회사 대웅 보툴리눔 독소를 포함하는 안정한 액상 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0762897B1 (en) * 1994-06-02 2003-04-02 Elan Drug Delivery Limited Method of preventing aggregation of proteins/peptides upon rehydration or thawing
US7201912B2 (en) * 2002-04-12 2007-04-10 Emergent Biodefense Operation Lansing Inc. Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis
JO3324B1 (ar) * 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
CN100556400C (zh) * 2006-07-20 2009-11-04 上海交通大学 载有活性疫苗或抗体的多糖玻璃体微粒的制备方法
EP2068834A2 (en) * 2006-09-08 2009-06-17 Becton, Dickinson & Company Stable powder formulations of aluma-dsorbed vaccines
CA2681567C (en) * 2007-03-22 2016-07-19 The Regents Of The University Of Colorado, A Body Corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
EP2320945A4 (en) * 2008-07-30 2013-02-27 Emergent Biosolutions Inc STABLE VACCINE FORMULATIONS AGAINST ANTHRAX
US20110212127A1 (en) * 2008-09-24 2011-09-01 Stabilitech Ltd. Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
EP2381959A1 (en) * 2009-01-22 2011-11-02 Pharmathene Inc. Stable vaccine compositions and methods of use

Also Published As

Publication number Publication date
WO2014004578A1 (en) 2014-01-03
AU2013280480A1 (en) 2015-01-22
RU2014151424A (ru) 2016-08-20
CA2877130A1 (en) 2014-01-03
JP2015525748A (ja) 2015-09-07
HK1207312A1 (en) 2016-01-29
SG11201408262XA (en) 2015-01-29
AU2013280480B2 (en) 2018-03-15
KR20150034170A (ko) 2015-04-02
EP2863898A4 (en) 2016-04-27
EP2863898A1 (en) 2015-04-29
CN104470506A (zh) 2015-03-25
IL236380A0 (en) 2015-02-26
US20150335752A1 (en) 2015-11-26

Similar Documents

Publication Publication Date Title
IN2015MN00038A (es)
PH12017502233A1 (en) Formulations for neoplasia vaccines and methods of preparing thereof
MX2013007657A (es) Oligodesoxinucleotidos inmunoestimulantes.
MY168959A (en) Vaccine compositions for the prevention of dengue virus infection
MX2013013800A (es) Oligodesoxinucleotidos inmunoestimuladores.
PH12014502875A1 (en) Vaccine compositions for prevention against dengue virus infection
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
BR112013003772A2 (pt) composições de compostos modificadores de resposta imunológica lipidadas, formulações e métodos
HUE044841T2 (hu) TLR4 agonistákat tartalmazó javított adjuváns készítmények és azok alkalmazási eljárásai
MX2013013801A (es) Oligodesoxinucleotidos inmunoestimuladores.
IN2015DN02729A (es)
JO3362B1 (ar) الحفظ بالتبريد لخلايا سرطان الموت الخلوي المبرمج للاستعمال في العلاج المناعي ضد السرطان
EA201590491A1 (ru) Иммуногенная композиция
NZ708016A (en) Lyophilized preparations of melphalan flufenamide
WO2013006569A3 (en) Herpes virus vaccine and methods of use
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
IN2015KN00516A (es)
IL236476A0 (en) Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it
EA201491845A1 (ru) Получение стерильных активных фармацевтических ингредиентов
WO2012078051A3 (en) IPN Vaccine
CL2015001618A1 (es) Adyuvante de vacunación, preparación y vacunas que lo contienen
GB2515222A (en) Use of flagellin as a vaccine